Investor Type | Firm |
Industries | BioTech • Medical Devices (& Hospital Services) |
Investing | France |
Investment Range | $1,400,000 - $15,200,000 |
Emertec Gestion is a venture capital firm created in Grenoble in 1999 with the aim of energizing seed investment. Today, the firm has evolved into a national capital venture company, managing 140 million euros, and is recognized for its unique investment strategy and its close relationships with key players in targeted sectors. Emertec specializes in investing in companies that are operating in the clean technology, software, healthcare, semiconductor, and mobile technology sectors. Their investment approach is predicated on two major trends that compel all economic players to rethink their offerings, integrate major innovations, or even overhaul their business models profoundly. These trends are the imperative of sustainable growth and the anticipated long-term rise in energy costs, which often prove to be interconnected and complementary. Emertec's mission is to create value by turning technological breakthroughs into commercial and financial successes. They have forged strong bonds with large industrial actors, many of whom are investors in their funds. This proximity provides their portfolio companies with access to a unique network, visibility on the medium to long-term needs of major clients, and significant commercial opportunities. The strategy of Emertec is executed by an experienced and recognized team capable of driving projects from the conceptual phase to profitable sale, ensuring the full deployment of the concerned value proposition. Emertec actively invests in Biotech, Medical Devices, and Hospital Services with an investment range of 1,400,000 to 15,200,000 euros, demonstrating their commitment to fostering growth and innovation in these vital areas of technology.